|
| 
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
FEATURES |
 |
 |
|
 |
Taking antiviral technology global
 |
|
| Malaysia-based BioValence is developing next-generation antiviral technologies and multifunctional drugs that target viruses at multiple points of their life cycle |
|
 |
|
|
|
|
|
 |
 |
 |
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
PEOPLE |
 |
 |
|
 |
Bio-Xcell appoints Mr Rizatuddin Ramli as CEO
 |
|
| Malaysian Bio-XCell Sdn Bhd has announced the appointment of Rizatuddin Ramli as its new chief executive officer following the resignation of its founding CEO, Mr Raja Ridzwa Raja Abd Aziz, who took up a business venture in the education industry |
|
 |
|
|
 |
'You will see more Hovid subsidiaries coming up in APAC'
 |
|
| Hovid Berhad is a diversified pharmaceutical company based in Perak, Malaysia. Listed on the main board of Kuala Lumpur stock exchange Hovid (formerly known as Ho Yan Hor) has to its credit years of experience in the pharmaceutical industry |
|
 |
|
|
|
 |
 |
 |
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
EVENTS |
 |
 |
|
|
|
 |
Gleneagles to organize GCP workshop in Malaysia
 |
|
| Gleneagles Intan Medical Centre in association with GleneaglesCRC, a leading clinical research organization in Australasia is organizing a three day workshop on the theme "GCP Idol: Bring your Research Team to Stardom & Excel in Asia" in Kuala Lumpur |
|
 |
|
|
|
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
PRODUCTS |
 |
 |
|
|
|
 |
Malaysia's Biotek purchases MIT 1000 System
 |
|
| MIT recently signed Biotek as its Distributor for Malaysia and other Association of Southeast Asian Nations (ASEAN) which includes Indonesia, Singapore, The Philippines, Thailand, Cambodia and others |
|
 |
|
|
|
 |
 |
 |
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
TRENDS & ANALYSIS |
 |
 |
|
 |
Malaysia biotech industry to surge by 2012
 |
|
| Driven by factors like, strong R&D base, government support, active private sector participation, and high investments, the Malaysian biotech industry is likely to grow at the CAGR of around 16 percent during 2010-2012
|
|
 |
|
|
|
|
|
 |
 |
 |
 |
|
|
|
|
|